These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11436539)

  • 1. Fungal infections in lung transplantation. Incidence, risk factors and prognostic significance.
    Ruffini E; Baldi S; Rapellino M; Cavallo A; Parola A; Robbiano F; Cappello N; Mancuso M
    Sarcoidosis Vasc Diffuse Lung Dis; 2001 Jun; 18(2):181-90. PubMed ID: 11436539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients.
    Helmi M; Love RB; Welter D; Cornwell RD; Meyer KC
    Chest; 2003 Mar; 123(3):800-8. PubMed ID: 12628881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mold infections in lung transplant recipients.
    Bhaskaran A; Hosseini-Moghaddam SM; Rotstein C; Husain S
    Semin Respir Crit Care Med; 2013 Jun; 34(3):371-9. PubMed ID: 23821511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aspergillosis in pulmonary transplantation].
    de Pablo A; Ussetti P; Cruz Carreño M; Lázaro T; Ferreiro MJ; López A; Mendaza P; Estada J
    Enferm Infecc Microbiol Clin; 2000 May; 18(5):209-14. PubMed ID: 10974763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infection in lung transplantation].
    Gavaldà J; Román A
    Enferm Infecc Microbiol Clin; 2007 Dec; 25(10):639-49; quiz 650. PubMed ID: 18053475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspergillus infections in lung transplant recipients: risk factors and outcome.
    Solé A; Morant P; Salavert M; Pemán J; Morales P;
    Clin Microbiol Infect; 2005 May; 11(5):359-65. PubMed ID: 15819861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome.
    Benedetti E; Gruessner AC; Troppmann C; Papalois BE; Sutherland DE; Dunn DL; Gruessner RW
    J Am Coll Surg; 1996 Oct; 183(4):307-16. PubMed ID: 8843258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of invasive respiratory disease caused by emerging non-Aspergillus molds in lung transplant recipients.
    Peghin M; Monforte V; Martin-Gomez MT; Ruiz-Camps I; Berastegui C; Saez B; Riera J; Solé J; Gavaldá J; Roman A
    Transpl Infect Dis; 2016 Feb; 18(1):70-8. PubMed ID: 26678668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive fungal infections in lung transplantation: role of aerosolised amphotericin B.
    Solé A
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S161-5. PubMed ID: 19013342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal prophylaxis in lung transplantation.
    Avery RK
    Semin Respir Crit Care Med; 2011 Dec; 32(6):717-26. PubMed ID: 22167399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation.
    Bando K; Paradis IL; Komatsu K; Konishi H; Matsushima M; Keena RJ; Hardesty RL; Armitage JM; Griffith BP
    J Thorac Cardiovasc Surg; 1995 Jan; 109(1):49-57; discussion 57-9. PubMed ID: 7815807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pulmonary infections after lung transplantation].
    Czebe K; Antus B; Varga M; Csiszér E
    Orv Hetil; 2008 Jan; 149(3):99-109. PubMed ID: 18194917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of anti-fungal management in lung transplantation.
    Dummer JS; Lazariashvilli N; Barnes J; Ninan M; Milstone AP
    J Heart Lung Transplant; 2004 Dec; 23(12):1376-81. PubMed ID: 15607667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole.
    Feist A; Lee R; Osborne S; Lane J; Yung G
    J Heart Lung Transplant; 2012 Nov; 31(11):1177-81. PubMed ID: 22841559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saprophytic fungal infections and lung transplantation--revisited.
    Paradowski LJ
    J Heart Lung Transplant; 1997 May; 16(5):524-31. PubMed ID: 9171271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.
    Castroagudín JF; Pontón C; Bustamante M; Otero E; Martínez J; Tomé S; Conde R; Segade FR; Delgado M; Brage A; Galbán C; Varo E
    Transplant Proc; 2005 Nov; 37(9):3965-7. PubMed ID: 16386598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants.
    Minari A; Husni R; Avery RK; Longworth DL; DeCamp M; Bertin M; Schilz R; Smedira N; Haug MT; Mehta A; Gordon SM
    Transpl Infect Dis; 2002 Dec; 4(4):195-200. PubMed ID: 12535262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole.
    Hayes D; Ball AM; Mansour HM; Martin CA; Flynn JD
    Exp Clin Transplant; 2011 Dec; 9(6):399-404. PubMed ID: 22142048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
    Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
    J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saprophytic fungal infections and complications involving the bronchial anastomosis following human lung transplantation.
    Nunley DR; Gal AA; Vega JD; Perlino C; Smith P; Lawrence EC
    Chest; 2002 Oct; 122(4):1185-91. PubMed ID: 12377840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.